Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

The glutaredoxin mono- and di-thiol mechanisms for deglutathionylation are functionally equivalent: implications for redox systems biology.

Mashamaite LN, Rohwer JM, Pillay CS.

Biosci Rep. 2015 Feb 25;35(1). pii: e00173. doi: 10.1042/BSR20140157.

2.

Implementation of adolescent-friendly voluntary medical male circumcision using a school based recruitment program in rural KwaZulu-Natal, South Africa.

Montague C, Ngcobo N, Mahlase G, Frohlich J, Pillay C, Yende-Zuma N, Humphries H, Dellar R, Naidoo K, Karim QA.

PLoS One. 2014 May 2;9(5):e96468. doi: 10.1371/journal.pone.0096468. eCollection 2014.

3.

From top-down to bottom-up: computational modeling approaches for cellular redoxin networks.

Pillay CS, Hofmeyr JH, Mashamaite LN, Rohwer JM.

Antioxid Redox Signal. 2013 Jun 1;18(16):2075-86. doi: 10.1089/ars.2012.4771. Epub 2013 Feb 4. Review.

PMID:
23249367
4.

The logic of kinetic regulation in the thioredoxin system.

Pillay CS, Hofmeyr JH, Rohwer JM.

BMC Syst Biol. 2011 Jan 25;5:15. doi: 10.1186/1752-0509-5-15.

5.

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D; CAPRISA 004 Trial Group.

Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19. Erratum in: Science. 2011 Jul 29;333(6042):524.

6.

HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy.

Pillay V, Pillay C, Kantor R, Venter F, Levin L, Morris L.

AIDS Res Hum Retroviruses. 2008 Nov;24(11):1449-54. doi: 10.1089/aid.2008.0180.

PMID:
19000027
7.

Enzymes or redox couples? The kinetics of thioredoxin and glutaredoxin reactions in a systems biology context.

Pillay CS, Hofmeyr JH, Olivier BG, Snoep JL, Rohwer JM.

Biochem J. 2009 Jan 1;417(1):269-75. doi: 10.1042/BJ20080690.

8.

The burden of asymptomatic sexually transmitted infections among men in Carletonville, South Africa: implications for syndromic management.

Lewis DA, Pillay C, Mohlamonyane O, Vezi A, Mbabela S, Mzaidume Y, Radebe F.

Sex Transm Infect. 2008 Oct;84(5):371-6. doi: 10.1136/sti.2008.029751. Epub 2008 Apr 2.

PMID:
18385225
9.
10.

Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial.

Pawar KS, Bhoite RR, Pillay CP, Chavan SC, Malshikare DS, Garad SG.

Lancet. 2006 Dec 16;368(9553):2136-41.

PMID:
17174705
11.

Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.

Snoeck J, Kantor R, Shafer RW, Van Laethem K, Deforche K, Carvalho AP, Wynhoven B, Soares MA, Cane P, Clarke J, Pillay C, Sirivichayakul S, Ariyoshi K, Holguin A, Rudich H, Rodrigues R, Bouzas MB, Brun-V├ęzinet F, Reid C, Cahn P, Brigido LF, Grossman Z, Soriano V, Sugiura W, Phanuphak P, Morris L, Weber J, Pillay D, Tanuri A, Harrigan RP, Camacho R, Schapiro JM, Katzenstein D, Vandamme AM.

Antimicrob Agents Chemother. 2006 Feb;50(2):694-701.

12.

Laboratory selection for and characteristics of pyrethroid resistance in the malaria vector Anopheles funestus.

Hunt RH, Brooke BD, Pillay C, Koekemoer LL, Coetzee M.

Med Vet Entomol. 2005 Sep;19(3):271-5.

PMID:
16134975
13.

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.

Kantor R, Katzenstein DA, Efron B, Carvalho AP, Wynhoven B, Cane P, Clarke J, Sirivichayakul S, Soares MA, Snoeck J, Pillay C, Rudich H, Rodrigues R, Holguin A, Ariyoshi K, Bouzas MB, Cahn P, Sugiura W, Soriano V, Brigido LF, Grossman Z, Morris L, Vandamme AM, Tanuri A, Phanuphak P, Weber JN, Pillay D, Harrigan PR, Camacho R, Schapiro JM, Shafer RW.

PLoS Med. 2005 Apr;2(4):e112. Epub 2005 Apr 26.

14.

Characterization of human immunodeficiency virus type 1 from a previously unexplored region of South Africa with a high HIV prevalence.

Bessong PO, Larry Obi C, Cilliers T, Choge I, Phoswa M, Pillay C, Papathanasopoulos M, Morris L.

AIDS Res Hum Retroviruses. 2005 Jan;21(1):103-9.

PMID:
15665650
15.

Sensitivity of HIV type 1 subtype C isolates to the entry inhibitor T-20.

Cilliers T, Patience T, Pillay C, Papathanasopoulos M, Morris L.

AIDS Res Hum Retroviruses. 2004 May;20(5):477-82.

PMID:
15186521
16.

Low frequency of the V106M mutation among HIV-1 subtype C-infected pregnant women exposed to nevirapine.

Morris L, Pillay C, Chezzi C, Lupondwana P, Ntsala M, Levin L, Venter F, Martinson N, Gray G, McIntyre J.

AIDS. 2003 Jul 25;17(11):1698-700.

PMID:
12853755
17.

Cathepsin B stability, but not activity, is affected in cysteine:cystine redox buffers.

Pillay CS, Dennison C.

Biol Chem. 2002 Jul-Aug;383(7-8):1199-204.

PMID:
12437106
18.

Lower dose of ciprofloxacin is adequate for the treatment of Neisseria gonorrhoeae in KwaZulu Natal, South Africa.

Moodley P, Pillay C, Nzimande G, Coovadia YM, Sturm AW.

Int J Antimicrob Agents. 2002 Oct;20(4):248-52.

PMID:
12385679
19.

HIV-1 subtype C reverse transcriptase sequences from drug-naive pregnant women in South Africa.

Pillay C, Bredell H, McIntyre J, Gray G, Morris L.

AIDS Res Hum Retroviruses. 2002 May 20;18(8):605-10.

PMID:
12036490
20.

Endolysosomal proteolysis and its regulation.

Pillay CS, Elliott E, Dennison C.

Biochem J. 2002 May 1;363(Pt 3):417-29. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk